Cyril Amarchand Mangaldas Advised The Book Running Lead Managers On Anthem Biosciences Limited’s IPO

Cyril Amarchand Mangaldas advised the book running lead managers on Anthem Biosciences Limited’s IPO

Cyril Amarchand Mangaldas advised the book running lead managers — JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, and Nomura Financial Advisory and Securities (India) Private Limited — in connection with the initial public offering (IPO) of Anthem Biosciences Limited.

Anthem is an innovation-driven and technology-focused contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing. The IPO was a pure offer for sale of equity shares by certain existing shareholders, aggregating to ₹33,950 million. The equity shares were listed on the stock exchanges on July 21, 2025, with the issue oversubscribed 63.86 times, delivering a premium of 26.85% over the issue price of ₹570.

The Cyril Amarchand Mangaldas deal team was led by Reuben Chacko (Partner & Regional Co-Head – Capital Markets – South) and Vartika Jain (Partner), with assistance from Bhaskar Kumar (Associate), Dhruv Sharma (Associate), Prakhar Jain (Associate), Joe George (Associate), and Rakshitha V (Associate).

Click to know more about Cyril Amarchand Mangaldas

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 88796 34922.